Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease

被引:1014
作者
Hart, Gerald W. [1 ]
Slawson, Chad [1 ]
Ramirez-Correa, Genaro [2 ]
Lagerlof, Olof [1 ]
机构
[1] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21205 USA
来源
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 | 2011年 / 80卷
关键词
O-GlcNAc; translation; diabetes; Alzheimer's disease; cancer; LINKED N-ACETYLGLUCOSAMINE; MUTATIONAL HOT-SPOT; RNA-POLYMERASE-II; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; POSTTRANSLATIONAL MODIFICATION; NUCLEOCYTOPLASMIC PROTEINS; NUCLEAR-PORE; STRUCTURAL INSIGHTS;
D O I
10.1146/annurev-biochem-060608-102511
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
O-GlcNAcylation is the addition of beta-D-N-acetylglucosamine to serine or threonine residues of nuclear and cytoplasmic proteins. O-linked N-acetylglucosamine (O-GlcNAc) was not discovered until the early 1980s and still remains difficult to detect and quantify. Nonetheless, O-GlcNAc is highly abundant and cycles on proteins with a timescale similar to protein phosphorylation. O-GlcNAc occurs in organisms ranging from some bacteria to protozoans and metazoans, including plants and nematodes up the evolutionary tree to man. O-GlcNAcylation is mostly on nuclear proteins, but it occurs in all intracellular compartments, including mitochondria. Recent glycomic analyses have shown that O-GlcNAcylation has surprisingly extensive cross talk with phosphorylation, where it serves as a nutrient/stress sensor to modulate signaling, transcription, and cytoskeletal functions. Abnormal amounts of O-GlcNAcylation underlie the etiology of insulin resistance and glucose toxicity in diabetes, and this type of modification plays a direct role in neurodegenerative disease. Many oncogenic proteins and tumor suppressor proteins are also regulated by O-GlcNAcylation. Current data justify extensive efforts toward a better understanding of this invisible, yet abundant, modification. As tools for the study of O-GlcNAc become more facile and available, exponential growth in this area of research will eventually take place.
引用
收藏
页码:825 / 858
页数:34
相关论文
共 230 条
[1]   Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer's disease treatment studies [J].
Alexander, GE ;
Chen, K ;
Pietrini, P ;
Rapoport, SI ;
Reiman, EM .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (05) :738-745
[2]   The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine [J].
Arnold, CS ;
Johnson, GVW ;
Cole, RN ;
Dong, DLY ;
Lee, M ;
Hart, GW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :28741-28744
[3]   Identification of the major site of O-linked β-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1 [J].
Ball, LE ;
Berkaw, MN ;
Buse, MG .
MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (02) :313-323
[4]   Molecular characterization of nucleocytosolic O-GlcNAc transferases of Giardia lamblia and Cryptosporidium parvum [J].
Banerjee, Sulagna ;
Robbins, Phillips W. ;
Samuelson, John .
GLYCOBIOLOGY, 2009, 19 (04) :331-336
[5]   Large-scale characterization of HeLa cell nuclear phosphoproteins [J].
Beausoleil, SA ;
Jedrychowski, M ;
Schwartz, D ;
Elias, JE ;
Villén, J ;
Li, JX ;
Cohn, MA ;
Cantley, LC ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (33) :12130-12135
[6]   VIRION BASIC PHOSPHOPROTEIN FROM HUMAN CYTOMEGALO-VIRUS CONTAINS O-LINKED N-ACETYLGLUCOSAMINE [J].
BENKO, DM ;
HALTIWANGER, RS ;
HART, GW ;
GIBSON, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2573-2577
[7]   Evidence for genetic linkage of Alzheimer's disease to chromosome 10q [J].
Bertram, L ;
Blacker, D ;
Mullin, K ;
Keeney, D ;
Jones, J ;
Basu, S ;
Yhu, S ;
McInnis, MG ;
Go, RCP ;
Vekrellis, K ;
Selkoe, DJ ;
Saunders, AJ ;
Tanzi, RE .
SCIENCE, 2000, 290 (5500) :2302-+
[8]  
Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO
[9]  
2-N
[10]   The cellular fate of glucose and its relevance in type 2 diabetes [J].
Bouché, C ;
Serdy, S ;
Kahn, CR ;
Goldfine, AB .
ENDOCRINE REVIEWS, 2004, 25 (05) :807-830